ARTIVION, INC. (AORT) insider trading

By person

33 insiders · 344 transactions

26.2×

J. Patrick Mackin holds 26.2 times base salary in stock. $21.91M of shares against $835.15K in salary for 2025.

Salary from the company's own proxy. The shares are what J. Patrick Mackin last reported holding, valued at $24.97, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

James P Mackin

President & CEO

$117.36K (1)

$29.72M (41)

−$29.60M

877,275

1.80%

$21.91M

+139.0%

Jean F Holloway

SVP, General Counsel

—

$7.82M (54) scheduled

−$7.82M

184,118

0.3776%

$4.60M

+368.8%

Marshall S. Stanton

SVP, Clinical & MD Affair

—

$6.07M (35) scheduled

−$6.07M

60,097

0.1233%

$1.50M

+868.4%

David Ashley Lee

Executive VP, COO & CFO

—

$4.99M (14) scheduled

−$4.99M

394,217

0.8085%

$9.84M

+29.9%

John E Davis

Chief Commercial Officer

$176.86K (2)

$4.48M (37) scheduled

−$4.31M

230,794

0.4734%

$5.76M

+643.8%

Amy Horton

VP, Chief Accounting Officer

—

$4.23M (43) scheduled

−$4.23M

139,088

0.2853%

$3.47M

+82.8%

Andrew M Green

SVP, Regulatory and Quality

—

$1.88M (16) scheduled

−$1.88M

40,160

0.0824%

$1.00M

+49.9%

Ronald D McCall

Director

—

$1.32M (15)

−$1.32M

137,768

0.2826%

$3.44M

−18.6%

Lance A Berry

EVP, COO, CFO & Treasurer

—

$1.01M (7)

−$1.01M

210,112

0.4309%

$5.25M

—

C Elkins Ronald

Director

—

$1.01M (12)

−$1.01M

64,843

0.1330%

$1.62M

−36.2%

Dennis B Maier

SVP, Operations

—

$813.80K (16)

−$813.80K

34,724

0.0712%

$867.06K

+239.8%

Scott B Capps

VP, Clinical Research

—

$812.46K (5) scheduled

−$812.46K

153,203

0.3142%

$3.83M

+54.1%

Matthew A Getz

VP, Human Resources

—

$575.72K (13)

−$575.72K

34,116

0.0700%

$851.88K

+103,282%

David C Gale

VP, Research & Development

—

$392.50K (2) scheduled

−$392.50K

77,135

0.1582%

$1.93M

+11.5%

Harvey Morgan

Director

—

$325.43K (3)

−$325.43K

220,802

0.4529%

$5.51M

+6.5%

Rochelle L. Maney

VP, Quality

—

$275.76K (9)

−$275.76K

46,536

0.0954%

$1.16M

+215.7%

Elizabeth A Hoff

Director

—

$189.41K (1)

−$189.41K

34,765

0.0713%

$868.08K

—

James Bullock

Director

$166.27K (1)

—

+$166.27K

76,223

0.1563%

$1.90M

+2,438%

James Benson

Director

—

$45.60K (1)

−$45.60K

54,086

0.1109%

$1.35M

−12.9%

Florian Tyrs

VP, Global Operations

—

$29.52K (3)

−$29.52K

21,558

0.0442%

$538.30K

+49.8%

Anthony B. Semedo

Director

$313.54K (3)

$316.66K (2)

−$3.11K

46,960

0.0963%

$1.17M

—

Daniel J Bevevino

Director

—

157,637

0.3233%

$3.94M

+67.5%

Thomas F Ackerman

Director

—

157,472

0.3230%

$3.93M

+67.4%

Jon W Salveson

Director

—

137,416

0.2818%

$3.43M

+85.5%

Jeffrey H Burbank

Director

—

61,372

0.1259%

$1.53M

+1,641%

Marna P Borgstrom

Director

—

56,938

0.1168%

$1.42M

—

William Robert Matthews

Senior VP, Operations, Quality

—

39,883

0.0818%

$995.88K

+110.2%

Michael S Simpson

SVP, Regulatory Affairs and QA

—

33,698

0.0691%

$841.44K

+184.9%

Franz Peter Barthold

VP, Research & Development

—

32,516

0.0667%

$811.92K

+369.0%

James M McDermid

SVP, CHRO

—

30,806

0.0632%

$769.23K

+616.1%

Sherry M Saurini

VP, Quality

—

25,084

0.0514%

$626.35K

−4.2%

Thomas J Bogenschuetz

VP, EMEA & General Manager

—

23,451

0.0481%

$585.57K

+76.2%

Robert C Thomson

VP Research & Development

—

13,291

0.0273%

$331.88K

—

ARTIVION, INC.

What the insiders did Net selling

By person